Intralymphatic immunotherapy: Time interval between injections is essential

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 3, 2014, Pages 930-931

  Kündig, Thomas M ^a   Johansen, Pål ^a   Bachmann, Martin F ^a   Cardell, Lars O ^b   Senti, Gabriela ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G4; PEPTIDE;

ANTIGEN SPECIFICITY; CELL MATURATION; CLINICAL PRACTICE; FOOD AND DRUG ADMINISTRATION; GRASS POLLEN; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; INTRALYMPHATIC DRUG ADMINISTRATION; INTRALYMPHATIC IMMUNOTHERAPY; LETTER; LYMPH FOLLICLE; MAINTENANCE DRUG DOSE; MEMORY CELL; MYCOBACTERIUM BOVIS BCG; NONHUMAN; OSMOTIC PUMP; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REGULATORY T LYMPHOCYTE; RHINOCONJUNCTIVITIS; T LYMPHOCYTE;

ALLERGENS; HUMANS; IMMUNOTHERAPY; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 84896708970     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.11.036     Document Type: Letter

References (11)

1. M. Witten, H.J. Malling, L. Blom, B.C. Poulsen, and L.K. Poulsen Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? J Allergy Clin Immunol 132 2013 1248 1252.e5
2. G. Senti, B.M. Prinz Vavricka, I. Erdmann, M.I. Diaz, R. Markus, and S.J. McCormack et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial Proc Natl Acad Sci U S A 105 2008 17908 17912
3. G. Senti, R. Crameri, D. Kuster, P. Johansen, J.M. Martinez-Gomez, and N. Graf et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections J Allergy Clin Immunol 129 2012 1290 1296
4. T. Hylander, L. Latif, U. Petersson-Westin, and L.O. Cardell Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis J Allergy Clin Immunol 131 2013 412 420
5. C.A. Siegrist Vaccine immunology S.A. Plotkin, Vaccines (6th ed.) 2013 Elsevier 14 32
6. General recommendation on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). 2011. Available from www.cdc.gov. Accessed January 3, 2014.
7. R.M. Kedl, J.W. Kappler, and P. Marrack Epitope dominance, competition and T cell affinity maturation Curr Opin Immunol 15 2003 120 127
8. T. Lovgren, P. Baumgaertner, S. Wieckowski, E. Devevre, P. Guillaume, and I. Luescher et al. Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose Cancer Immunol Immunother 61 2012 817 826
9. D. Patel, P. Couroux, P. Hickey, A.M. Salapatek, P. Laidler, and M. Larche et al. Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study J Allergy Clin Immunol 131 2013 103 109.e1-7
10. J.C. Guery, F. Galbiati, S. Smiroldo, and L. Adorini Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice J Exp Med 183 1996 485 497
11. G. Senti, P. Johansen, and T.M. Kundig Intralymphatic immunotherapy: from the rationale to human applications Curr Top Microbiol Immunol 352 2011 71 84